nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0916	0.137	CbGbCtD
Riluzole—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0829	0.124	CbGbCtD
Riluzole—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0829	0.124	CbGbCtD
Riluzole—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0794	0.119	CbGbCtD
Riluzole—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0614	0.092	CbGbCtD
Riluzole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.053	0.0794	CbGbCtD
Riluzole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0498	0.0746	CbGbCtD
Riluzole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0498	0.0746	CbGbCtD
Riluzole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0451	0.0675	CbGbCtD
Riluzole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0378	0.0566	CbGbCtD
Riluzole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0342	0.0511	CbGbCtD
Riluzole—SLC7A11—digestive system—acquired immunodeficiency syndrome	0.0018	0.0725	CbGeAlD
Riluzole—SLC7A11—spinal cord—acquired immunodeficiency syndrome	0.00165	0.0666	CbGeAlD
Riluzole—SLC7A11—lung—acquired immunodeficiency syndrome	0.0015	0.0606	CbGeAlD
Riluzole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00148	0.0598	CbGeAlD
Riluzole—SLC7A11—nervous system—acquired immunodeficiency syndrome	0.00139	0.0561	CbGeAlD
Riluzole—SLC7A11—central nervous system—acquired immunodeficiency syndrome	0.00134	0.054	CbGeAlD
Riluzole—SCN5A—digestive system—acquired immunodeficiency syndrome	0.00108	0.0436	CbGeAlD
Riluzole—SLC7A11—brain—acquired immunodeficiency syndrome	0.00107	0.0429	CbGeAlD
Riluzole—SCN5A—blood—acquired immunodeficiency syndrome	0.00103	0.0416	CbGeAlD
Riluzole—SCN5A—vagina—acquired immunodeficiency syndrome	0.000958	0.0385	CbGeAlD
Riluzole—SCN5A—nervous system—acquired immunodeficiency syndrome	0.000839	0.0338	CbGeAlD
Riluzole—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000807	0.0325	CbGeAlD
Riluzole—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000704	0.0283	CbGeAlD
Riluzole—SCN5A—brain—acquired immunodeficiency syndrome	0.000641	0.0258	CbGeAlD
Riluzole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000571	0.023	CbGeAlD
Riluzole—ABCG2—blood—acquired immunodeficiency syndrome	0.000565	0.0227	CbGeAlD
Riluzole—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000563	0.0227	CbGeAlD
Riluzole—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000547	0.022	CbGeAlD
Riluzole—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000544	0.0219	CbGeAlD
Riluzole—CYP1A2—blood—acquired immunodeficiency syndrome	0.000544	0.0219	CbGeAlD
Riluzole—CYP1A1—blood—acquired immunodeficiency syndrome	0.000537	0.0216	CbGeAlD
Riluzole—ABCG2—vagina—acquired immunodeficiency syndrome	0.000524	0.0211	CbGeAlD
Riluzole—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000497	0.02	CbGeAlD
Riluzole—ABCG2—lung—acquired immunodeficiency syndrome	0.000495	0.0199	CbGeAlD
Riluzole—CYP1A2—lung—acquired immunodeficiency syndrome	0.000477	0.0192	CbGeAlD
Riluzole—CYP1A1—lung—acquired immunodeficiency syndrome	0.00047	0.0189	CbGeAlD
Riluzole—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000436	0.0175	CbGeAlD
Riluzole—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000419	0.0169	CbGeAlD
Riluzole—ABCG2—brain—acquired immunodeficiency syndrome	0.000351	0.0141	CbGeAlD
Riluzole—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000339	0.0136	CbGeAlD
Riluzole—CYP1A1—brain—acquired immunodeficiency syndrome	0.000333	0.0134	CbGeAlD
Riluzole—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000322	0.0129	CbGeAlD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.00035	CcSEcCtD
Riluzole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000349	CcSEcCtD
Riluzole—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000107	0.000348	CcSEcCtD
Riluzole—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000348	CcSEcCtD
Riluzole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000348	CcSEcCtD
Riluzole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000348	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000348	CcSEcCtD
Riluzole—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000347	CcSEcCtD
Riluzole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000347	CcSEcCtD
Riluzole—Pain—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000345	CcSEcCtD
Riluzole—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000345	CcSEcCtD
Riluzole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000345	CcSEcCtD
Riluzole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000345	CcSEcCtD
Riluzole—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000345	CcSEcCtD
Riluzole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000344	CcSEcCtD
Riluzole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000344	CcSEcCtD
Riluzole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000343	CcSEcCtD
Riluzole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000105	0.000343	CcSEcCtD
Riluzole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000343	CcSEcCtD
Riluzole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000343	CcSEcCtD
Riluzole—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000343	CcSEcCtD
Riluzole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000342	CcSEcCtD
Riluzole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000105	0.000342	CcSEcCtD
Riluzole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000341	CcSEcCtD
Riluzole—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000341	CcSEcCtD
Riluzole—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000341	CcSEcCtD
Riluzole—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00034	CcSEcCtD
Riluzole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00034	CcSEcCtD
Riluzole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00034	CcSEcCtD
Riluzole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000339	CcSEcCtD
Riluzole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000339	CcSEcCtD
Riluzole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000339	CcSEcCtD
Riluzole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000339	CcSEcCtD
Riluzole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000338	CcSEcCtD
Riluzole—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000338	CcSEcCtD
Riluzole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000337	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000337	CcSEcCtD
Riluzole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000336	CcSEcCtD
Riluzole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000335	CcSEcCtD
Riluzole—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000334	CcSEcCtD
Riluzole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000333	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000333	CcSEcCtD
Riluzole—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000332	CcSEcCtD
Riluzole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000332	CcSEcCtD
Riluzole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000332	CcSEcCtD
Riluzole—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000331	CcSEcCtD
Riluzole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000102	0.000331	CcSEcCtD
Riluzole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000331	CcSEcCtD
Riluzole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000331	CcSEcCtD
Riluzole—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000101	0.00033	CcSEcCtD
Riluzole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000101	0.00033	CcSEcCtD
Riluzole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.00033	CcSEcCtD
Riluzole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.00033	CcSEcCtD
Riluzole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000329	CcSEcCtD
Riluzole—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000329	CcSEcCtD
Riluzole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000101	0.000329	CcSEcCtD
Riluzole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000329	CcSEcCtD
Riluzole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000328	CcSEcCtD
Riluzole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000328	CcSEcCtD
Riluzole—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000328	CcSEcCtD
Riluzole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Pain—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.0001	0.000326	CcSEcCtD
Riluzole—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.98e-05	0.000325	CcSEcCtD
Riluzole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.97e-05	0.000325	CcSEcCtD
Riluzole—Headache—Nevirapine—acquired immunodeficiency syndrome	9.96e-05	0.000324	CcSEcCtD
Riluzole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000323	CcSEcCtD
Riluzole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000323	CcSEcCtD
Riluzole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000323	CcSEcCtD
Riluzole—Infection—Saquinavir—acquired immunodeficiency syndrome	9.92e-05	0.000323	CcSEcCtD
Riluzole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.9e-05	0.000322	CcSEcCtD
Riluzole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.89e-05	0.000322	CcSEcCtD
Riluzole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.87e-05	0.000321	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000321	CcSEcCtD
Riluzole—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.86e-05	0.000321	CcSEcCtD
Riluzole—Shock—Saquinavir—acquired immunodeficiency syndrome	9.82e-05	0.00032	CcSEcCtD
Riluzole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.00032	CcSEcCtD
Riluzole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.81e-05	0.000319	CcSEcCtD
Riluzole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.81e-05	0.000319	CcSEcCtD
Riluzole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.79e-05	0.000319	CcSEcCtD
Riluzole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.79e-05	0.000319	CcSEcCtD
Riluzole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.77e-05	0.000318	CcSEcCtD
Riluzole—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.76e-05	0.000318	CcSEcCtD
Riluzole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.75e-05	0.000317	CcSEcCtD
Riluzole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.72e-05	0.000316	CcSEcCtD
Riluzole—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.71e-05	0.000316	CcSEcCtD
Riluzole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.7e-05	0.000316	CcSEcCtD
Riluzole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9.7e-05	0.000316	CcSEcCtD
Riluzole—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.69e-05	0.000316	CcSEcCtD
Riluzole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.68e-05	0.000315	CcSEcCtD
Riluzole—Rash—Stavudine—acquired immunodeficiency syndrome	9.68e-05	0.000315	CcSEcCtD
Riluzole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.67e-05	0.000315	CcSEcCtD
Riluzole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.67e-05	0.000315	CcSEcCtD
Riluzole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.66e-05	0.000314	CcSEcCtD
Riluzole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.65e-05	0.000314	CcSEcCtD
Riluzole—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.64e-05	0.000314	CcSEcCtD
Riluzole—Headache—Stavudine—acquired immunodeficiency syndrome	9.62e-05	0.000313	CcSEcCtD
Riluzole—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.61e-05	0.000313	CcSEcCtD
Riluzole—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9.6e-05	0.000313	CcSEcCtD
Riluzole—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.59e-05	0.000312	CcSEcCtD
Riluzole—Pain—Delavirdine—acquired immunodeficiency syndrome	9.59e-05	0.000312	CcSEcCtD
Riluzole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.59e-05	0.000312	CcSEcCtD
Riluzole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.57e-05	0.000312	CcSEcCtD
Riluzole—Rash—Abacavir—acquired immunodeficiency syndrome	9.53e-05	0.00031	CcSEcCtD
Riluzole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.52e-05	0.00031	CcSEcCtD
Riluzole—Oedema—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.00031	CcSEcCtD
Riluzole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.00031	CcSEcCtD
Riluzole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.52e-05	0.00031	CcSEcCtD
Riluzole—Headache—Abacavir—acquired immunodeficiency syndrome	9.47e-05	0.000308	CcSEcCtD
Riluzole—Infection—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000308	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	9.45e-05	0.000308	CcSEcCtD
Riluzole—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.44e-05	0.000307	CcSEcCtD
Riluzole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.44e-05	0.000307	CcSEcCtD
Riluzole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.38e-05	0.000305	CcSEcCtD
Riluzole—Shock—Lamivudine—acquired immunodeficiency syndrome	9.37e-05	0.000305	CcSEcCtD
Riluzole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	9.34e-05	0.000304	CcSEcCtD
Riluzole—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.33e-05	0.000304	CcSEcCtD
Riluzole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.32e-05	0.000304	CcSEcCtD
Riluzole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.31e-05	0.000303	CcSEcCtD
Riluzole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.31e-05	0.000303	CcSEcCtD
Riluzole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000302	CcSEcCtD
Riluzole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.27e-05	0.000302	CcSEcCtD
Riluzole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	9.25e-05	0.000301	CcSEcCtD
Riluzole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000301	CcSEcCtD
Riluzole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	9.24e-05	0.000301	CcSEcCtD
Riluzole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	9.22e-05	0.0003	CcSEcCtD
Riluzole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.21e-05	0.0003	CcSEcCtD
Riluzole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.17e-05	0.000299	CcSEcCtD
Riluzole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.14e-05	0.000298	CcSEcCtD
Riluzole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.14e-05	0.000298	CcSEcCtD
Riluzole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.13e-05	0.000297	CcSEcCtD
Riluzole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.13e-05	0.000297	CcSEcCtD
Riluzole—Nausea—Stavudine—acquired immunodeficiency syndrome	9.12e-05	0.000297	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.09e-05	0.000296	CcSEcCtD
Riluzole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.08e-05	0.000296	CcSEcCtD
Riluzole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.03e-05	0.000294	CcSEcCtD
Riluzole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.02e-05	0.000294	CcSEcCtD
Riluzole—Nausea—Abacavir—acquired immunodeficiency syndrome	8.98e-05	0.000292	CcSEcCtD
Riluzole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.96e-05	0.000292	CcSEcCtD
Riluzole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.95e-05	0.000292	CcSEcCtD
Riluzole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000291	CcSEcCtD
Riluzole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.91e-05	0.00029	CcSEcCtD
Riluzole—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.9e-05	0.00029	CcSEcCtD
Riluzole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.00029	CcSEcCtD
Riluzole—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.9e-05	0.00029	CcSEcCtD
Riluzole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.87e-05	0.000289	CcSEcCtD
Riluzole—Pain—Ritonavir—acquired immunodeficiency syndrome	8.87e-05	0.000289	CcSEcCtD
Riluzole—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.87e-05	0.000289	CcSEcCtD
Riluzole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000289	CcSEcCtD
Riluzole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.87e-05	0.000289	CcSEcCtD
Riluzole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.82e-05	0.000287	CcSEcCtD
Riluzole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.79e-05	0.000286	CcSEcCtD
Riluzole—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.78e-05	0.000286	CcSEcCtD
Riluzole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.68e-05	0.000283	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.68e-05	0.000282	CcSEcCtD
Riluzole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.64e-05	0.000281	CcSEcCtD
Riluzole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.62e-05	0.000281	CcSEcCtD
Riluzole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.61e-05	0.00028	CcSEcCtD
Riluzole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.61e-05	0.00028	CcSEcCtD
Riluzole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.55e-05	0.000278	CcSEcCtD
Riluzole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.55e-05	0.000278	CcSEcCtD
Riluzole—Pain—Saquinavir—acquired immunodeficiency syndrome	8.54e-05	0.000278	CcSEcCtD
Riluzole—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.54e-05	0.000278	CcSEcCtD
Riluzole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000276	CcSEcCtD
Riluzole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.49e-05	0.000276	CcSEcCtD
Riluzole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.48e-05	0.000276	CcSEcCtD
Riluzole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.48e-05	0.000276	CcSEcCtD
Riluzole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	8.47e-05	0.000276	CcSEcCtD
Riluzole—Rash—Zidovudine—acquired immunodeficiency syndrome	8.41e-05	0.000274	CcSEcCtD
Riluzole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.41e-05	0.000274	CcSEcCtD
Riluzole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.4e-05	0.000274	CcSEcCtD
Riluzole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.38e-05	0.000273	CcSEcCtD
Riluzole—Headache—Zidovudine—acquired immunodeficiency syndrome	8.36e-05	0.000272	CcSEcCtD
Riluzole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.29e-05	0.00027	CcSEcCtD
Riluzole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.28e-05	0.00027	CcSEcCtD
Riluzole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.26e-05	0.000269	CcSEcCtD
Riluzole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.24e-05	0.000268	CcSEcCtD
Riluzole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000268	CcSEcCtD
Riluzole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.22e-05	0.000268	CcSEcCtD
Riluzole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000267	CcSEcCtD
Riluzole—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.2e-05	0.000267	CcSEcCtD
Riluzole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000267	CcSEcCtD
Riluzole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.2e-05	0.000267	CcSEcCtD
Riluzole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.16e-05	0.000266	CcSEcCtD
Riluzole—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.14e-05	0.000265	CcSEcCtD
Riluzole—Pain—Lamivudine—acquired immunodeficiency syndrome	8.14e-05	0.000265	CcSEcCtD
Riluzole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.05e-05	0.000262	CcSEcCtD
Riluzole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.02e-05	0.000261	CcSEcCtD
Riluzole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.94e-05	0.000258	CcSEcCtD
Riluzole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.93e-05	0.000258	CcSEcCtD
Riluzole—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.92e-05	0.000258	CcSEcCtD
Riluzole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000257	CcSEcCtD
Riluzole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.89e-05	0.000257	CcSEcCtD
Riluzole—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.89e-05	0.000257	CcSEcCtD
Riluzole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.000255	CcSEcCtD
Riluzole—Rash—Indinavir—acquired immunodeficiency syndrome	7.82e-05	0.000255	CcSEcCtD
Riluzole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.82e-05	0.000254	CcSEcCtD
Riluzole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.79e-05	0.000254	CcSEcCtD
Riluzole—Headache—Indinavir—acquired immunodeficiency syndrome	7.77e-05	0.000253	CcSEcCtD
Riluzole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.75e-05	0.000252	CcSEcCtD
Riluzole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.67e-05	0.00025	CcSEcCtD
Riluzole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.64e-05	0.000249	CcSEcCtD
Riluzole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.57e-05	0.000246	CcSEcCtD
Riluzole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000245	CcSEcCtD
Riluzole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.53e-05	0.000245	CcSEcCtD
Riluzole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.45e-05	0.000243	CcSEcCtD
Riluzole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.44e-05	0.000242	CcSEcCtD
Riluzole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.42e-05	0.000241	CcSEcCtD
Riluzole—Rash—Efavirenz—acquired immunodeficiency syndrome	7.39e-05	0.000241	CcSEcCtD
Riluzole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.38e-05	0.00024	CcSEcCtD
Riluzole—Nausea—Indinavir—acquired immunodeficiency syndrome	7.37e-05	0.00024	CcSEcCtD
Riluzole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.35e-05	0.000239	CcSEcCtD
Riluzole—Headache—Efavirenz—acquired immunodeficiency syndrome	7.34e-05	0.000239	CcSEcCtD
Riluzole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.34e-05	0.000239	CcSEcCtD
Riluzole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.16e-05	0.000233	CcSEcCtD
Riluzole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.13e-05	0.000232	CcSEcCtD
Riluzole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.1e-05	0.000231	CcSEcCtD
Riluzole—Rash—Delavirdine—acquired immunodeficiency syndrome	7.07e-05	0.00023	CcSEcCtD
Riluzole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.07e-05	0.00023	CcSEcCtD
Riluzole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.06e-05	0.00023	CcSEcCtD
Riluzole—Headache—Delavirdine—acquired immunodeficiency syndrome	7.03e-05	0.000229	CcSEcCtD
Riluzole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.02e-05	0.000228	CcSEcCtD
Riluzole—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.96e-05	0.000227	CcSEcCtD
Riluzole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.86e-05	0.000223	CcSEcCtD
Riluzole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.83e-05	0.000222	CcSEcCtD
Riluzole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.83e-05	0.000222	CcSEcCtD
Riluzole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.74e-05	0.000219	CcSEcCtD
Riluzole—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.66e-05	0.000217	CcSEcCtD
Riluzole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.6e-05	0.000215	CcSEcCtD
Riluzole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.59e-05	0.000215	CcSEcCtD
Riluzole—Rash—Ritonavir—acquired immunodeficiency syndrome	6.54e-05	0.000213	CcSEcCtD
Riluzole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.53e-05	0.000213	CcSEcCtD
Riluzole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.52e-05	0.000212	CcSEcCtD
Riluzole—Headache—Ritonavir—acquired immunodeficiency syndrome	6.5e-05	0.000212	CcSEcCtD
Riluzole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.35e-05	0.000207	CcSEcCtD
Riluzole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000205	CcSEcCtD
Riluzole—Rash—Saquinavir—acquired immunodeficiency syndrome	6.29e-05	0.000205	CcSEcCtD
Riluzole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.29e-05	0.000205	CcSEcCtD
Riluzole—Headache—Saquinavir—acquired immunodeficiency syndrome	6.25e-05	0.000204	CcSEcCtD
Riluzole—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.16e-05	0.000201	CcSEcCtD
Riluzole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.06e-05	0.000197	CcSEcCtD
Riluzole—Rash—Lamivudine—acquired immunodeficiency syndrome	6e-05	0.000195	CcSEcCtD
Riluzole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6e-05	0.000195	CcSEcCtD
Riluzole—Headache—Lamivudine—acquired immunodeficiency syndrome	5.97e-05	0.000194	CcSEcCtD
Riluzole—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.93e-05	0.000193	CcSEcCtD
Riluzole—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.66e-05	0.000184	CcSEcCtD
